Artigos com autorizações de acesso público - Colin PillaiSaiba mais
Não disponível em nenhum local: 1
Fostering drug discovery and development in Africa
S Winks, JG Woodland, GC Pillai, K Chibale
Nature Medicine 28 (8), 1523-1526, 2022
Autorizações: Bill & Melinda Gates Foundation
Disponíveis em algum local: 4
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions
MC Kjellsson, LE Via, A Goh, D Weiner, KM Low, S Kern, G Pillai, ...
Antimicrobial agents and chemotherapy 56 (1), 446-457, 2012
Autorizações: US National Institutes of Health
Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of Africa
G Pillai, G Davies, P Denti, JL Steimer, H McIlleron, S Zvada, E Chigutsa, ...
CPT: pharmacometrics & systems pharmacology 2 (8), 1-4, 2013
Autorizações: Wellcome Trust
Emerging therapeutics, technologies, and drug development strategies to address patient nonadherence and improve tuberculosis treatment
M Garcia-Cremades, BP Solans, N Strydom, B Vrijens, GC Pillai, ...
Annual review of pharmacology and toxicology 62 (1), 197-210, 2022
Autorizações: Bill & Melinda Gates Foundation
A commentary on establishing a local centre of excellence for research and training in pharmacometrics: lessons from the pharmacometrics Africa–Uganda chapter
L Najjemba, AN Kawuma, FW Ojara, B Obura, C Sekaggya‐Wiltshire, ...
British Journal of Clinical Pharmacology 89 (9), 2658, 2023
Autorizações: Wellcome Trust
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.